An association between the presence of intra-tumoral B cells and the therapeutic efficacy of anti-PD-L1 antibodies in NSCLC has been reported, but there are no reports yet on TNFSF13B and PD-L1 expression in NSCLC specimens [30]. Here, TNFSF13B is linked to non-small cell lung carcinoma.